CD44 and neoplasm: Although—theoretically—blocking the CD44 ligand hyaluronan might prevent peritoneal dissemination, its therapeutic value is controversial: both tumour promoting and tumour repressing effects were reported after blocking CD44 intraperitoneally with hyaluronan [81–83].